Last reviewed · How we verify
NCT07412769
ASMact: Study on Management of Bronchial Asthma
trial in Asthma Acute in 500 participants. Currently enrolling.
31 May 2026
Quick facts
| Lead sponsor | Meyer Children's Hospital IRCCS |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 5 November 2025 |
| Primary completion | 31 May 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 2 locations across Italy |
Conditions studied
- Asthma Acute — all drugs for Asthma Acute →
- Asthma Childhood — all drugs for Asthma Childhood →
- Asthma in Children — all drugs for Asthma in Children →
- Asthma Crisis — all drugs for Asthma Crisis →
Sponsor
Meyer Children's Hospital IRCCS
Who can join
Adults 6 to 17, any sex, with Asthma Acute or Asthma Childhood. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07412769
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asthma Acute
Currently open trials in the same condition.
- NCT07431021 — Children's Health, Respiratory Inflammation and Short-term Air Pollution · NA · recruiting
- NCT07055542 — Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study · NA · recruiting
- NCT06377345 — Remote Patient Monitoring Solution for Chronic Respiratory Disease Management · NA · recruiting
Other Meyer Children's Hospital IRCCS trials
Trials by the same sponsor.
- NCT07412782 — REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) · NA · recruiting
- NCT07363304 — Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People Wi · recruiting
- NCT07468461 — CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome · recruiting
- NCT07348263 — EFESO: Study on Juvenile Onset Eosinophilic Fasciitis · recruiting
- NCT06921993 — Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07412769 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Meyer Children's Hospital IRCCS
- Last refreshed: 17 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07412769.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing